Doximity, Inc.
DOCS
$57.33
-$1.42-2.42%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 138.29M | 168.60M | 136.83M | 126.68M | 118.06M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 138.29M | 168.60M | 136.83M | 126.68M | 118.06M |
| Cost of Revenue | 14.47M | 14.18M | 13.68M | 13.55M | 12.57M |
| Gross Profit | 123.82M | 154.42M | 123.16M | 113.13M | 105.49M |
| SG&A Expenses | 50.17M | 51.99M | 44.25M | 44.30M | 43.31M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 89.44M | 88.59M | 81.17M | 80.42M | 76.02M |
| Operating Income | 48.85M | 80.02M | 55.67M | 46.26M | 42.04M |
| Income Before Tax | 58.39M | 89.84M | 62.17M | 53.17M | 47.95M |
| Income Tax Expenses | -4.06M | 14.64M | 18.02M | 11.79M | 7.34M |
| Earnings from Continuing Operations | 62.46M | 75.20M | 44.15M | 41.38M | 40.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 62.46M | 75.20M | 44.15M | 41.38M | 40.62M |
| EBIT | 48.85M | 80.02M | 55.67M | 46.26M | 42.04M |
| EBITDA | 50.08M | 81.17M | 56.88M | 47.52M | 43.28M |
| EPS Basic | 0.33 | 0.40 | 0.24 | 0.22 | 0.22 |
| Normalized Basic EPS | 0.19 | 0.30 | 0.22 | 0.18 | 0.16 |
| EPS Diluted | 0.31 | 0.37 | 0.22 | 0.21 | 0.20 |
| Normalized Diluted EPS | 0.18 | 0.28 | 0.20 | 0.17 | 0.15 |
| Average Basic Shares Outstanding | 188.36M | 187.16M | 186.25M | 185.61M | 186.76M |
| Average Diluted Shares Outstanding | 202.99M | 202.23M | 200.41M | 199.22M | 201.11M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |